Matthew Taylor
Stock Analyst at Jefferies
(4.42)
# 1,207
Out of 5,010 analysts
674
Total ratings
55.1%
Success rate
6.8%
Average return
Main Sectors:
Stocks Rated by Matthew Taylor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SYK Stryker | Reiterated: Buy | $455 → $405 | $278.77 | +45.28% | 36 | Sep 22, 2026 | |
| BSX Boston Scientific | Reiterated: Buy | $60 | $43.88 | +36.74% | 54 | Sep 11, 2026 | |
| EW Edwards Lifesciences | Reiterated: Buy | $102 → $105 | $88.08 | +19.21% | 69 | Sep 11, 2026 | |
| BDX Becton, Dickinson and Company | Reiterated: Buy | $210 | $181.97 | +15.40% | 31 | Sep 8, 2026 | |
| ESTA Establishment Labs Holdings | Reiterated: Buy | $63 → $105 | $63.70 | +64.84% | 11 | Sep 8, 2026 | |
| MDT Medtronic | Reiterated: Hold | $95 | $87.09 | +9.08% | 41 | Sep 2, 2026 | |
| ABT Abbott Laboratories | Reiterated: Buy | $135 | $100.95 | +33.73% | 44 | Aug 21, 2026 | |
| GEHC GE HealthCare Technologies | Reiterated: Buy | $90 → $92 | $66.46 | +38.43% | 13 | Jul 30, 2026 | |
| RMD ResMed | Reiterated: Hold | $245 → $225 | $222.83 | +0.97% | 16 | Jul 10, 2026 | |
| LNTH Lantheus Holdings | Reiterated: Buy | $105 → $110 | $99.51 | +10.54% | 13 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $400 | $132.84 | +201.11% | 30 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $112 | $86.64 | +29.27% | 36 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $19 | $23.48 | -19.08% | 34 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $105 → $115 | $75.69 | +51.94% | 30 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $16.57 | +189.68% | 11 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $15 → $12 | $18.47 | -35.03% | 3 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $18.79 | n/a | 1 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $79 → $80 | $76.99 | n/a | 13 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $130 → $110 | $91.34 | n/a | 28 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $19.15 | n/a | 1 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $1.05 | n/a | 4 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $412.18 | n/a | 24 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $215 → $145 | $126.32 | n/a | 32 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33.00 → $34.50 | $16.15 | n/a | 2 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $16 → $15 | $14.22 | n/a | 23 | Apr 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $0.5 → $6 | $10.06 | n/a | 3 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $48 | $16.64 | n/a | 16 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $105 | $46.69 | n/a | 1 | Feb 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $14 | $6.08 | n/a | 1 | Jan 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 364.00 → CHF 255.00 | CHF 252.40 | n/a | 13 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $230 | $318.86 | n/a | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 → $5.5 | $9.10 | n/a | 2 | Mar 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $162.34 | n/a | 2 | Feb 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €49.00 | €21.73 | n/a | 21 | Jan 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $38.65 | n/a | 1 | Dec 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $1.5 → $1 | $6.91 | n/a | 9 | Mar 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $17 → $16 | $15.60 | n/a | 2 | Jul 19, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 → $2.5 | $0.000001 | n/a | 2 | May 12, 2016 |
Stryker
Sep 22, 2026
Reiterated: Buy
Price Target: $455 → $405
Current: $278.77
Upside: +45.28%
Boston Scientific
Sep 11, 2026
Reiterated: Buy
Price Target: $60
Current: $43.88
Upside: +36.74%
Edwards Lifesciences
Sep 11, 2026
Reiterated: Buy
Price Target: $102 → $105
Current: $88.08
Upside: +19.21%
Becton, Dickinson and Company
Sep 8, 2026
Reiterated: Buy
Price Target: $210
Current: $181.97
Upside: +15.40%
Establishment Labs Holdings
Sep 8, 2026
Reiterated: Buy
Price Target: $63 → $105
Current: $63.70
Upside: +64.84%
Medtronic
Sep 2, 2026
Reiterated: Hold
Price Target: $95
Current: $87.09
Upside: +9.08%
Abbott Laboratories
Aug 21, 2026
Reiterated: Buy
Price Target: $135
Current: $100.95
Upside: +33.73%
GE HealthCare Technologies
Jul 30, 2026
Reiterated: Buy
Price Target: $90 → $92
Current: $66.46
Upside: +38.43%
ResMed
Jul 10, 2026
Reiterated: Hold
Price Target: $245 → $225
Current: $222.83
Upside: +0.97%
Lantheus Holdings
Mar 18, 2026
Reiterated: Buy
Price Target: $105 → $110
Current: $99.51
Upside: +10.54%
Feb 19, 2026
Reiterated: Buy
Price Target: $400
Current: $132.84
Upside: +201.11%
Feb 13, 2026
Reiterated: Buy
Price Target: $112
Current: $86.64
Upside: +29.27%
Feb 12, 2026
Reiterated: Hold
Price Target: $19
Current: $23.48
Upside: -19.08%
Jan 8, 2026
Reiterated: Buy
Price Target: $105 → $115
Current: $75.69
Upside: +51.94%
Nov 7, 2025
Reiterated: Buy
Price Target: $48
Current: $16.57
Upside: +189.68%
Oct 3, 2025
Reiterated: Hold
Price Target: $15 → $12
Current: $18.47
Upside: -35.03%
Aug 25, 2025
Initiated Coverage: Buy
Price Target: $19
Current: $18.79
Upside: n/a
Aug 7, 2025
Reiterated: Buy
Price Target: $79 → $80
Current: $76.99
Upside: n/a
Aug 7, 2025
Reiterated: Hold
Price Target: $130 → $110
Current: $91.34
Upside: n/a
Aug 5, 2025
Reiterated: Buy
Price Target: $28
Current: $19.15
Upside: n/a
Jun 4, 2025
Reiterated: Buy
Price Target: $18
Current: $1.05
Upside: n/a
May 2, 2025
Reiterated: Hold
Price Target: n/a
Current: $412.18
Upside: n/a
May 1, 2025
Reiterated: Hold
Price Target: $215 → $145
Current: $126.32
Upside: n/a
Apr 28, 2025
Reiterated: Buy
Price Target: $33.00 → $34.50
Current: $16.15
Upside: n/a
Apr 14, 2025
Upgraded: Buy
Price Target: $16 → $15
Current: $14.22
Upside: n/a
Mar 4, 2025
Reiterated: Sell
Price Target: $0.5 → $6
Current: $10.06
Upside: n/a
Jul 16, 2024
Reiterated: Buy
Price Target: $50 → $48
Current: $16.64
Upside: n/a
Feb 1, 2024
Reiterated: Hold
Price Target: $105
Current: $46.69
Upside: n/a
Jan 19, 2024
Initiated Coverage: Buy
Price Target: $14
Current: $6.08
Upside: n/a
Oct 28, 2022
Reiterated: Hold
Price Target: CHF 364.00 → CHF 255.00
Current: CHF 252.40
Upside: n/a
Oct 12, 2022
Initiated Coverage: Buy
Price Target: $230
Current: $318.86
Upside: n/a
Mar 1, 2022
Reiterated: Hold
Price Target: $7 → $5.5
Current: $9.10
Upside: n/a
Feb 7, 2022
Upgraded: Buy
Price Target: n/a
Current: $162.34
Upside: n/a
Jan 25, 2022
Reiterated: Buy
Price Target: €49.00
Current: €21.73
Upside: n/a
Dec 6, 2019
Reiterated: Hold
Price Target: n/a
Current: $38.65
Upside: n/a
Mar 8, 2018
Reiterated: Sell
Price Target: $1.5 → $1
Current: $6.91
Upside: n/a
Jul 19, 2017
Reiterated: Hold
Price Target: $17 → $16
Current: $15.60
Upside: n/a
May 12, 2016
Reiterated: Hold
Price Target: $5 → $2.5
Current: $0.000001
Upside: n/a